Xinming G. Zhao

Chinese Academy Of Medical Sciences And Peking Union Medical College, 17, Panjiayuan NanLi, Chaoyang District
Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Distinguishing between hepatocellular adenoma and well-differentiated hepatocellular carcinoma using MRI and clinical feature-based nomogram model.

Distinguishing between hepatocellular adenoma and well-differentiated hepatocellular carcinoma using MRI and clinical feature-based nomogram model.

Journal: Clinical radiology

Published: December 18, 2024

Virtual MR Elastography and Multi-b-value DWI Models for Predicting Microvascular Invasion in Solitary BCLC Stage A Hepatocellular Carcinoma.

Virtual MR Elastography and Multi-b-value DWI Models for Predicting Microvascular Invasion in Solitary BCLC Stage A Hepatocellular Carcinoma.

Journal: Academic radiology

Published: June 12, 2024

An MRI-based model for preoperative prediction of tertiary lymphoid structures in patients with gallbladder cancer.

An MRI-based model for preoperative prediction of tertiary lymphoid structures in patients with gallbladder cancer.

Journal: Insights into imaging

Published: June 10, 2024

Baseline Body Composition and 3D-Extracellular Volume Fraction for Predicting Pancreatic Fistula after Distal Pancreatectomy in Pancreatic Body and/or Tail Adenocarcinoma.

Baseline Body Composition and 3D-Extracellular Volume Fraction for Predicting Pancreatic Fistula after Distal Pancreatectomy in Pancreatic Body and/or Tail Adenocarcinoma.

Journal: Academic radiology

Published: May 22, 2024

Publisher Correction: Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.

Publisher Correction: Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.

Journal: European radiology

Published: January 29, 2024

Prognostic performance of MRI LI-RADS version 2018 features and clinical-pathological factors in alpha-fetoprotein-negative hepatocellular carcinoma.

Prognostic performance of MRI LI-RADS version 2018 features and clinical-pathological factors in alpha-fetoprotein-negative hepatocellular carcinoma.

Journal: Abdominal radiology (New York)

Published: December 31, 2023

Extracellular volume-based scoring system for tracking tumor progression in pancreatic cancer patients receiving intraoperative radiotherapy.

Extracellular volume-based scoring system for tracking tumor progression in pancreatic cancer patients receiving intraoperative radiotherapy.

Journal: Insights into imaging

Published: November 14, 2023

Microvascular invasion-negative hepatocellular carcinoma: Prognostic value of qualitative and quantitative Gd-EOB-DTPA MRI analysis.

Microvascular invasion-negative hepatocellular carcinoma: Prognostic value of qualitative and quantitative Gd-EOB-DTPA MRI analysis.

Journal: European journal of radiology

Published: August 16, 2023

A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma.

A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma.

Journal: Insights into imaging

Published: July 04, 2023

Determination of prognostic predictors in patients with solitary hepatocellular carcinoma: histogram analysis of multiparametric MRI.

Determination of prognostic predictors in patients with solitary hepatocellular carcinoma: histogram analysis of multiparametric MRI.

Journal: Abdominal radiology (New York)

Published: May 27, 2023

Prior information guided auto-segmentation of clinical target volume of tumor bed in postoperative breast cancer radiotherapy.

Prior information guided auto-segmentation of clinical target volume of tumor bed in postoperative breast cancer radiotherapy.

Journal: Radiation oncology (London, England)

Published: April 21, 2023

Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.

Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.

Journal: European radiology

Published: February 22, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026